• Approved drugs that were originally shown to normalize blood vessels surrounding tumors (to improve drug delivery to cancer cells) can enhance the delivery of anti-microbial medications to kill tuberculosis bacteria residing in the lungs
• These drugs (bevacizumab and losartan) alone and in combination with anti-microbial agents, promoted anti-bacterial host responses and improved health outcomes in lab models with tuberculosis

Congratulations on this achievement!

Click here to read more 

Research.com, a leading academic platform for researchers, has just released the 2023 Edition of its Ranking of Best Scientists in the field of Medicine.

Rakesh Jain was ranked #59 in the world ranking and #41 in United States. He has also been recognized with their Medicine Leader Award for 2023. Congratulations, Rakesh!